BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nozoe T, Matsumata T, Sugimachi K. Preoperative elevation of serum C-reactive protein is related to impaired immunity in patients with colorectal cancer. Am J Clin Oncol. 2000;23:263-266. [PMID: 10857890 DOI: 10.1097/00000421-200006000-00011] [Cited by in Crossref: 78] [Cited by in F6Publishing: 67] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Crozier JE, Leitch EF, Mckee RF, Anderson JH, Horgan PG, Mcmillan DC. Relationship between emergency presentation, systemic inflammatory response, and cancer-specific survival in patients undergoing potentially curative surgery for colon cancer. The American Journal of Surgery 2009;197:544-9. [DOI: 10.1016/j.amjsurg.2007.12.052] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
2 Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol. 2005;91:181-184. [PMID: 16118772 DOI: 10.1002/jso.20329] [Cited by in Crossref: 643] [Cited by in F6Publishing: 643] [Article Influence: 37.8] [Reference Citation Analysis]
3 Řı́hová B, Strohalm J, Kubáčková K, Jelı́nková M, Hovorka O, Kovář M, Plocová D, Šı́rová M, Št’astný M, Rozprimová L, Ulbrich K. Acquired and specific immunological mechanisms co-responsible for efficacy of polymer-bound drugs. Journal of Controlled Release 2002;78:97-114. [DOI: 10.1016/s0168-3659(01)00489-8] [Cited by in Crossref: 34] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
4 Roxburgh CS, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol. 2010;6:149-163. [PMID: 20021215 DOI: 10.2217/fon.09.136] [Cited by in Crossref: 525] [Cited by in F6Publishing: 532] [Article Influence: 43.8] [Reference Citation Analysis]
5 Da B, Luo S, Huang M, Song F, Ding R, Xiao Y, Fu Y, Yang Y, Wang H, Khalaf OI. Prediction of Hepatocellular Carcinoma Prognosis and Immune Cell Infiltration Using Gene Signature Associated with Inflammatory Response. Computational and Mathematical Methods in Medicine 2022;2022:1-24. [DOI: 10.1155/2022/2415129] [Reference Citation Analysis]
6 Uehara K, Nakanishi Y, Shimoda T, Taniguchi H, Akasu T, Moriya Y. Clinicopathological significance of microscopic abscess formation at the invasive margin of advanced low rectal cancer. Br J Surg. 2007;94:239-243. [PMID: 17094167 DOI: 10.1002/bjs.5575] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
7 Leung EY, Scott HR, McMillan DC. Clinical utility of the pretreatment glasgow prognostic score in patients with advanced inoperable non-small cell lung cancer. J Thorac Oncol 2012;7:655-62. [PMID: 22425914 DOI: 10.1097/JTO.0b013e318244ffe1] [Cited by in Crossref: 55] [Cited by in F6Publishing: 39] [Article Influence: 5.5] [Reference Citation Analysis]
8 Martling A, Granath F, Cedermark B, Johansson R, Holm T. Gender differences in the treatment of rectal cancer: A population based study. European Journal of Surgical Oncology (EJSO) 2009;35:427-33. [DOI: 10.1016/j.ejso.2008.03.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
9 Roxburgh CS, Wallace AM, Guthrie GK, Horgan PG, McMillan DC. Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative surgery for colon cancer. Colorectal Dis. 2010;12:987-994. [PMID: 25216413 DOI: 10.9738/intsurg-d-13-00118.1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
10 Shimada H, Kitabayashi H, Nabeya Y, Okazumi S, Matsubara H, Funami Y, Miyazawa Y, Shiratori T, Uno T, Itoh H, Ochiai T. Treatment response and prognosis of patients after recurrence of esophageal cancer. Surgery 2003;133:24-31. [PMID: 12563234 DOI: 10.1067/msy.2003.31] [Cited by in Crossref: 94] [Cited by in F6Publishing: 82] [Article Influence: 4.9] [Reference Citation Analysis]
11 Kaminski JM, Shinohara E, Summers JB, Niermann KJ, Morimoto A, Brousal J. The controversial abscopal effect. Cancer Treatment Reviews 2005;31:159-72. [DOI: 10.1016/j.ctrv.2005.03.004] [Cited by in Crossref: 147] [Cited by in F6Publishing: 136] [Article Influence: 8.6] [Reference Citation Analysis]
12 Lee JW, Sharma AR, Lee SS, Chun WJ, Kim HS. The C-reactive protein to albumin ratio predicts postoperative complication in patients who undergo gastrectomy for gastric cancer. Heliyon 2020;6:e04220. [PMID: 32577578 DOI: 10.1016/j.heliyon.2020.e04220] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Zheng BH, Yang LX, Sun QM, Fan HK, Duan M, Shi JY, Wang XY, Zhou J, Fan J, Ma ZY, Gao Q. A New Preoperative Prognostic System Combining CRP and CA199 For Patients with Intrahepatic Cholangiocarcinoma. Clin Transl Gastroenterol 2017;8:e118. [PMID: 28981082 DOI: 10.1038/ctg.2017.45] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
14 Kubo T, Ono S, Ueno H, Shinto E, Yamamoto J, Hase K. Elevated preoperative C-reactive protein levels are a risk factor for the development of postoperative infectious complications following elective colorectal surgery. Langenbecks Arch Surg 2013;398:965-71. [DOI: 10.1007/s00423-013-1107-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
15 Takamori S, Takada K, Shimokawa M, Matsubara T, Fujishita T, Ito K, Toyozawa R, Yamaguchi M, Okamoto T, Yoneshima Y, Tanaka K, Okamoto I, Tagawa T, Mori M. Clinical utility of pretreatment Glasgow prognostic score in non-small-cell lung cancer patients treated with immune checkpoint inhibitors. Lung Cancer 2021;152:27-33. [PMID: 33341085 DOI: 10.1016/j.lungcan.2020.11.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
16 Kaltenborn A, Schrem H, Reichert B, Braun F, Emmanouilidis N, Klempnauer J, Becker T, Heits N. The Glasgow Prognostic Score and its variants predict mortality in living donor but not in deceased donor liver transplantation for hepatocellular carcinoma: A double-center validation study. Hepatol Res 2017;47:783-92. [PMID: 27598002 DOI: 10.1111/hepr.12818] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
17 Říhová B, Strohalm J, Kubáčková K, Jelínková M, Rozprimová L, Á MŠ, Plocová D, Mrkvan T, Kovář M, Pokorná J, Etrych T, Ulbrich K. Drug-HPMA-HuIg Conjugates Effective Against Human Solid Cancer. In: Maeda H, Kabanov A, Kataoka K, Okano T, editors. Polymer Drugs in the Clinical Stage. Boston: Kluwer Academic Publishers; 2004. pp. 125-43. [DOI: 10.1007/0-306-47932-x_8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
18 Suh DH, Kim HS, Chung HH, Kim JW, Park NH, Song YS, Kang SB. Pre-operative systemic inflammatory response markers in predicting lymph node metastasis in endometrioid endometrial adenocarcinoma. Eur J Obstet Gynecol Reprod Biol 2012;162:206-10. [PMID: 22445206 DOI: 10.1016/j.ejogrb.2012.02.028] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
19 Katoh H, Yamashita K, Wang G, Sato T, Nakamura T, Watanabe M. Anastomotic leakage contributes to the risk for systemic recurrence in stage II colorectal cancer. J Gastrointest Surg 2011;15:120-9. [PMID: 21086058 DOI: 10.1007/s11605-010-1379-4] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 4.7] [Reference Citation Analysis]
20 Kobayashi Y, Inose H, Ushio S, Yuasa M, Hirai T, Yoshii T, Okawa A. Body Mass Index and Modified Glasgow Prognostic Score Are Useful Predictors of Surgical Site Infection After Spinal Instrumentation Surgery: A Consecutive Series. Spine 2020;45:E148-54. [DOI: 10.1097/brs.0000000000003226] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
21 Okugawa Y, Toiyama Y, Yamamoto A, Shigemori T, Kitamura A, Ichikawa T, Ide S, Kitajima T, Fujikawa H, Yasuda H, Okita Y, Hiro J, Araki T, Mcmillan DC, Miki C, Kusunoki M. Close Relationship Between Immunological/Inflammatory Markers and Myopenia and Myosteatosis in Patients With Colorectal Cancer: A Propensity Score Matching Analysis. Journal of Parenteral and Enteral Nutrition 2019;43:508-15. [DOI: 10.1002/jpen.1459] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
22 Hashimoto S, Tominaga T, Nonaka T, Hamada K, Araki M, Takeshita H, Fukuoka H, Wada H, To K, Komatsu H, Tanaka K, Sawai T, Nagayasu T. The C-reactive protein to albumin ratio predicts postoperative complications in oldest-old patients with colorectal cancer. Int J Colorectal Dis 2020;35:423-31. [PMID: 31897648 DOI: 10.1007/s00384-019-03491-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
23 Crozier JE, McKee RF, McArdle CS, Angerson WJ, Anderson JH, Horgan PG, McMillan DC. Preoperative but not postoperative systemic inflammatory response correlates with survival in colorectal cancer. Br J Surg. 2007;94:1028-1032. [PMID: 17437250 DOI: 10.1002/bjs.5706] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
24 Ishizuka M, Kita J, Shimoda M, Rokkaku K, Kato M, Sawada T, Kubota K. Systemic inflammatory response predicts postoperative outcome in patients with liver metastases from colorectal cancer. J Surg Oncol 2009;100:38-42. [DOI: 10.1002/jso.21294] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
25 Kocsis J, Mészáros T, Madaras B, Tóth EK, Kamondi S, Gál P, Varga L, Prohászka Z, Füst G. High levels of acute phase proteins and soluble 70 kDa heat shock proteins are independent and additive risk factors for mortality in colorectal cancer. Cell Stress Chaperones 2011;16:49-55. [PMID: 20730518 DOI: 10.1007/s12192-010-0220-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
26 Moyes LH, Leitch EF, McKee RF, Anderson JH, Horgan PG, McMillan DC. Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancer. Br J Cancer. 2009;100:1236-1239. [PMID: 19319134 DOI: 10.1038/sj.bjc.6604997] [Cited by in Crossref: 119] [Cited by in F6Publishing: 104] [Article Influence: 9.2] [Reference Citation Analysis]
27 Yuan C, Pan Y, Ning Y. Predictive Value of IL-6 Combined with NLR in Inflammation and Cancer. Cancer Invest 2021;39:489-504. [PMID: 34139921 DOI: 10.1080/07357907.2020.1858852] [Reference Citation Analysis]
28 Toiyama Y, Fujikawa H, Koike Y, Saigusa S, Inoue Y, Tanaka K, Mohri Y, Miki C, Kusunoki M. Evaluation of preoperative C-reactive protein aids in predicting poor survival in patients with curative colorectal cancer with poor lymph node assessment. Oncol Lett 2013;5:1881-8. [PMID: 23833661 DOI: 10.3892/ol.2013.1308] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
29 Okugawa Y, Toiyama Y, Fujikawa H, Kawamura M, Yasuda H, Yokoe T, Mochiki I, Okita Y, Ohi M, Nakatani K. Cumulative perioperative lymphocyte/C-reactive protein ratio as a predictor of the long-term outcomes of patients with colorectal cancer. Surg Today 2021. [PMID: 33954875 DOI: 10.1007/s00595-021-02291-9] [Reference Citation Analysis]
30 Yamamoto M, Yoshinaga K, Matsuyama A, Iwasa T, Osoegawa A, Tsujita E, Yamashita Y, Tsutsui S, Ishida T. Plasma D-Dimer Level as a Mortality Predictor in Patients with Advanced or Recurrent Colorectal Cancer. Oncology 2012;83:10-5. [DOI: 10.1159/000338329] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
31 Engelken FJ, Bettschart V, Rahman MQ, Parks RW, Garden OJ. Prognostic factors in the palliation of pancreatic cancer. Eur J Surg Oncol 2003;29:368-73. [PMID: 12711291 DOI: 10.1053/ejso.2002.1405] [Cited by in Crossref: 88] [Cited by in F6Publishing: 73] [Article Influence: 4.6] [Reference Citation Analysis]
32 Nozoe T, Korenaga D, Ohga T, Futatsugi M, Maehara Y. Suppression of the phytohemagglutinin response to lymphocytes is an independent prognosticator in patients with squamous cell carcinoma of the esophagus. Ann Thorac Surg. 2003;76:260-265. [PMID: 12842553 DOI: 10.1016/s0003-4975(03)00165-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
33 Chase D, Mclauchlan G, Eckersall PD, Parkin T, Pratschke K, Pratschke J. Acute phase protein levels in dogs with mast cell tumours and sarcomas. Veterinary Record 2012;170:648-648. [DOI: 10.1136/vr.100401] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
34 Toiyama Y, Miki C, Inoue Y, Tanaka K, Mohri Y, Kusunoki M. Evaluation of an inflammation-based prognostic score for the identification of patients requiring postoperative adjuvant chemotherapy for stage II colorectal cancer. Exp Ther Med 2011;2:95-101. [PMID: 22977476 DOI: 10.3892/etm.2010.175] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 4.1] [Reference Citation Analysis]
35 Chung YC, Chang YF. Serum C-reactive protein correlates with survival in colorectal cancer patients but is not an independent prognostic indicator. Eur J Gastroenterol Hepatol. 2003;15:369-373. [PMID: 12655256 DOI: 10.1097/00042737-200304000-00006] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 2.4] [Reference Citation Analysis]
36 Grose D, Devereux G, Brown L, Jones R, Sharma D, Selby C, Morrison DS, Docherty K, McIntosh D, McElhinney P, Nicolson M, McMillan DC, Milroy R. Simple and Objective Prediction of Survival in Patients with Lung Cancer: Staging the Host Systemic Inflammatory Response. Lung Cancer Int 2014;2014:731925. [PMID: 26316945 DOI: 10.1155/2014/731925] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
37 Roxburgh CS, Salmond JM, Horgan PG, Oien KA, McMillan DC. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer. Ann Surg. 2009;249:788-793. [PMID: 19387324 DOI: 10.1097/sla.0b013e3181a3e738] [Cited by in Crossref: 110] [Cited by in F6Publishing: 63] [Article Influence: 8.5] [Reference Citation Analysis]
38 Iwasaki Y, Ishizuka M, Kato M, Kita J, Shimoda M, Kubota K. Usefulness of an Inflammation-Based Prognostic Score (mGPS) for Predicting Survival in Patients with Unresectable Malignant Biliary Obstruction. World J Surg 2013;37:2222-8. [DOI: 10.1007/s00268-013-2075-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
39 Müller T, Sikora P, Offner G, Hoyer PF, Brodehl J. Recurrence of renal disease after kidney transplantation in children: 24 years of experience in a single center. Clin Nephrol 1998;49:82-90. [PMID: 9524777 [PMID: 9524777 DOI: 10.1097/sla.0b013e3181b16e24] [Cited by in Crossref: 75] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
40 McArdle CS, McMillan DC, Hole DJ. Male gender adversely affects survival following surgery for colorectal cancer. Br J Surg 2003;90:711-5. [PMID: 12808619 DOI: 10.1002/bjs.4098] [Cited by in Crossref: 98] [Cited by in F6Publishing: 90] [Article Influence: 5.2] [Reference Citation Analysis]
41 Suh S, Ahn H. A prospective study on C-reactive protein as a prognostic factor for survival time of terminally ill cancer patients. Support Care Cancer 2007;15:613-20. [DOI: 10.1007/s00520-006-0208-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
42 Lee WS, Baek JH, You DH, Nam MJ. Prognostic value of circulating cytokines for stage III colon cancer. J Surg Res. 2013;182:49-54. [PMID: 23010514 DOI: 10.1016/j.jss.2012.08.051] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
43 Tani M, Iida H, Maehira H, Mori H, Miyake T, Kaida S. A High C-Reactive Protein Level on Postoperative Day 7 is Associated with Poor Survival of Patients with Pancreatic Ductal Adenocarcinoma after Resection. Am Surg 2021;:31348211023406. [PMID: 34049444 DOI: 10.1177/00031348211023406] [Reference Citation Analysis]
44 Mori K, Toiyama Y, Saigusa S, Fujikawa H, Hiro J, Kobayashi M, Ohi M, Araki T, Inoue Y, Tanaka K. Systemic Analysis of Predictive Biomarkers for Recurrence in Colorectal Cancer Patients Treated with Curative Surgery. Dig Dis Sci. 2015;60:2477-2487. [PMID: 25840921 DOI: 10.1007/s10620-015-3648-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
45 Chiang JM, Chang CJ, Jiang SF, Yeh CY, You JF, Hsieh PS, Huang HY. Pre-operative serum albumin level substantially predicts post-operative morbidity and mortality among patients with colorectal cancer who undergo elective colectomy. Eur J Cancer Care (Engl) 2017;26. [PMID: 26526411 DOI: 10.1111/ecc.12403] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
46 Koike Y, Miki C, Okugawa Y, Yokoe T, Toiyama Y, Tanaka K, Inoue Y, Kusunoki M. Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer. J Surg Oncol 2008;98:540-4. [DOI: 10.1002/jso.21154] [Cited by in Crossref: 84] [Cited by in F6Publishing: 79] [Article Influence: 6.0] [Reference Citation Analysis]
47 Nikiteas NI, Tzanakis N, Gazouli M, Rallis G, Daniilidis K, Theodoropoulos G, Kostakis A, Peros G. Serum IL-6, TNFα and CRP levels in Greek colorectal cancer patients: Prognostic implications. World J Gastroenterol 2005; 11(11): 1639-1643 [PMID: 15786541 DOI: 10.3748/wjg.v11.i11.1639] [Cited by in CrossRef: 89] [Cited by in F6Publishing: 85] [Article Influence: 5.2] [Reference Citation Analysis]
48 Nozoe T, Ninomiya M, Maeda T, Matsukuma A, Nakashima H, Ezaki T. Prognostic nutritional index: a tool to predict the biological aggressiveness of gastric carcinoma. Surg Today. 2010;40:440-443. [PMID: 20425547 DOI: 10.1007/s00595-009-4065-y] [Cited by in Crossref: 121] [Cited by in F6Publishing: 130] [Article Influence: 10.1] [Reference Citation Analysis]
49 Knight K, Choong JX, McKee RF, Anderson JH, Horgan PG, McMillan DC, McDonald A, Roxburgh CS. The Influence of Systemic Inflammation on Treatment Response and Survival in Anal Squamous Cell Cancer. Clin Oncol (R Coll Radiol) 2021;33:e22-30. [PMID: 32709540 DOI: 10.1016/j.clon.2020.06.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Finlayson E. Invited commentary. Gender influences treatment and survival in colorectal cancer surgery. Dis Colon Rectum 2009;52:1991-3. [PMID: 19934919 DOI: 10.1097/01.dcr.0000364983.74288.29] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Bert M, Devilliers H, Orry D, Rat P, Facy O, Ortega-Deballon P. Preoperative inflammation is an independent factor of worse prognosis after colorectal cancer surgery. J Visc Surg 2021;158:305-11. [PMID: 33446466 DOI: 10.1016/j.jviscsurg.2020.08.001] [Reference Citation Analysis]
52 Chang PH, Pan YP, Fan CW, Tseng WK, Huang JS, Wu TH, Chou WC, Wang CH, Yeh KY. Pretreatment serum interleukin-1β, interleukin-6, and tumor necrosis factor-α levels predict the progression of colorectal cancer. Cancer Med 2016;5:426-33. [PMID: 26799163 DOI: 10.1002/cam4.602] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
53 De Magistris L, Paquette B, Orry D, Facy O, Di Giacomo G, Rat P, Binquet C, Ortega-Deballon P. Preoperative inflammation increases the risk of infection after elective colorectal surgery: results from a prospective cohort. Int J Colorectal Dis 2016;31:1611-7. [PMID: 27357511 DOI: 10.1007/s00384-016-2620-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
54 Crozier JE, McMillan DC, McArdle CS, Angerson WJ, Anderson JH, Horgan PG, McKee RF. Tumor size is associated with the systemic inflammatory response but not survival in patients with primary operable colorectal cancer. J Gastroenterol Hepatol 2007;22:2288-91. [PMID: 18031394 DOI: 10.1111/j.1440-1746.2006.04792.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
55 Rihova B. Clinical experience with anthracycline antibiotics–HPMA copolymer–human immunoglobulin conjugates. Advanced Drug Delivery Reviews 2009;61:1149-58. [DOI: 10.1016/j.addr.2008.12.017] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
56 Roxburgh CS, Crozier JE, Maxwell F, Foulis AK, Brown J, McKee RF, Anderson JH, Horgan PG, McMillan DC. Comparison of tumour-based (Petersen Index) and inflammation-based (Glasgow Prognostic Score) scoring systems in patients undergoing curative resection for colon cancer. Br J Cancer. 2009;100:701-706. [PMID: 19209171 DOI: 10.1038/sj.bjc.6604926] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 4.2] [Reference Citation Analysis]
57 Nozoe T, Mori E, Takahashi I, Ezaki T. Preoperative elevation of serum C-reactive protein as an independent prognostic indicator of colorectal carcinoma. Surg Today. 2008;38:597-602. [PMID: 18612783 DOI: 10.1007/s00595-007-3680-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
58 Nozoe T, Iguchi T, Maeda T, Kohno M, Ezaki T. Simple criteria to predict prognosis in colorectal carcinoma based on lymphopenia and thrombocytosis. Mol Clin Oncol 2013;1:171-4. [PMID: 24649142 DOI: 10.3892/mco.2012.32] [Reference Citation Analysis]
59 Koper-Lenkiewicz OM, Dymicka-Piekarska V, Milewska AJ, Zińczuk J, Kamińska J. The Relationship between Inflammation Markers (CRP, IL-6, sCD40L) and Colorectal Cancer Stage, Grade, Size and Location. Diagnostics (Basel) 2021;11:1382. [PMID: 34441316 DOI: 10.3390/diagnostics11081382] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Muñoz Gómez M, Llau Pitarch JV, Leal Noval SR, García Erce JA, Culebras Fernández JM. Transfusión sanguínea perioperatoria en el paciente neoplásico. I. Alteraciones inmunológicas y consecuencias clínicas. Cirugía Española 2002;72:160-8. [DOI: 10.1016/s0009-739x(02)72032-0] [Cited by in Crossref: 8] [Article Influence: 0.4] [Reference Citation Analysis]
61 Ytting H, Christensen IJ, Jensenius JC, Thiel S, Nielsen HJ. Preoperative mannan-binding lectin pathway and prognosis in colorectal cancer. Cancer Immunol Immunother. 2005;54:265-272. [PMID: 15449036 DOI: 10.1007/s00262-004-0594-9] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
62 Shiu YC, Lin JK, Huang CJ, Jiang JK, Wang LW, Huang HC, Yang SH. Is C-reactive protein a prognostic factor of colorectal cancer? Dis Colon Rectum. 2008;51:443-449. [PMID: 18172726 DOI: 10.1007/s10350-007-9133-z] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
63 Agalar C, Egeli T, Unek T, Ozbilgin M, Aysal A, Cevlik AD, Sagol O, Bacakoglu A, Ellidokuz H, Astarcioglu I. The Predictive Ability of the Glasgow Prognostic Score and Variants in Both Deceased Donor and Living Donor Liver Transplantation for Hepatocellular Cancer. Transplant Proc 2019;51:1134-8. [PMID: 31101186 DOI: 10.1016/j.transproceed.2019.02.004] [Reference Citation Analysis]
64 Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Kubota K. Inflammation-based prognostic system predicts survival after surgery for stage IV colorectal cancer. Am J Surg. 2013;205:22-28. [PMID: 23116639 DOI: 10.1016/j.amjsurg.2012.04.012] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
65 Kwon KA, Kim SH, Oh SY, Lee S, Han JY, Kim KH, Goh RY, Choi HJ, Park KJ, Roh MS. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer. BMC Cancer. 2010;10:203. [PMID: 20465852 DOI: 10.1186/1471-2407-10-203] [Cited by in Crossref: 69] [Cited by in F6Publishing: 72] [Article Influence: 5.8] [Reference Citation Analysis]
66 Smeets BJJ, Brinkman DJ, Horsten ECJ, Langius JAE, Rutten HJT, de Jonge WJ, Luyer MDP. The Effect of Myopenia on the Inflammatory Response Early after Colorectal Surgery. Nutr Cancer 2018;70:460-6. [PMID: 29537903 DOI: 10.1080/01635581.2018.1445763] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
67 Nozoe T, Korenaga D, Futatsugi M, Saeki H, Maehara Y, Sugimachi K. Immunohistochemical expression of C-reactive protein in squamous cell carcinoma of the esophagus - significance as a tumor marker. Cancer Lett. 2003;192:89-95. [PMID: 12637157 DOI: 10.1016/s0304-3835(02)00630-4] [Cited by in Crossref: 67] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
68 Miki C, Tanaka K, Inoue Y, Araki T, Ohi M, Mohri Y, Uchida K, Kusunoki M. Perioperative host-tumor inflammatory interactions: A potential trigger for disease recurrence following a curative resection for colorectal cancer. Surg Today 2008;38:579-84. [DOI: 10.1007/s00595-007-3674-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
69 Kjelgaard-hansen M, Jensen AL, Kristensen AT. Evaluation of a Commercially Available Human C-Reactive Protein (CRP) Turbidometric Immunoassay for Determination of Canine Serum CRP Concentration. Veterinary Clinical Pathology 2003;32:81-7. [DOI: 10.1111/j.1939-165x.2003.tb00319.x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
70 Shimada H, Nabeya Y, Okazumi S, Matsubara H, Miyazawa Y, Shihratori T, Hayashi H, Aoki T, Sugaya M, Gunji Y. Prognostic value of preoperative serum immunosuppressive acidic protein in patients with esophageal squamous cell carcinoma. Dis Esophagus. 2003;16:102-106. [PMID: 12823207 DOI: 10.1046/j.1442-2050.2003.00306.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]